A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
NCT05621733
·
clinicaltrials.gov ↗
RECRUITING
Status
127
Enrollment
INDUSTRY
Sponsor class
Conditions
Graft-versus-Host Disease
Interventions
OTHER:
ruxolitinib
Sponsor
Novartis Pharmaceuticals